- Home
- QTRX vs AVK Comparison
QTRX vs AVK Comparison
Compare QTRX & AVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QTRX
- AVK
- Stock Information
- Founded
- QTRX 2007
- AVK 2003
- Country
- QTRX United States
- AVK United States
- Employees
- QTRX N/A
- AVK N/A
- Industry
- QTRX Biotechnology: Laboratory Analytical Instruments
- AVK Trusts Except Educational Religious and Charitable
- Sector
- QTRX Industrials
- AVK Finance
- Exchange
- QTRX Nasdaq
- AVK Nasdaq
- Market Cap
- QTRX 387.3M
- AVK 424.5M
- IPO Year
- QTRX 2017
- AVK N/A
- Fundamental
- Price
- QTRX $7.55
- AVK $12.08
- Analyst Decision
- QTRX Strong Buy
- AVK
- Analyst Count
- QTRX 4
- AVK 0
- Target Price
- QTRX $23.25
- AVK N/A
- AVG Volume (30 Days)
- QTRX 623.1K
- AVK 112.9K
- Earning Date
- QTRX 03-17-2025
- AVK 01-01-0001
- Dividend Yield
- QTRX N/A
- AVK 11.85%
- EPS Growth
- QTRX N/A
- AVK N/A
- EPS
- QTRX N/A
- AVK N/A
- Revenue
- QTRX $133,809,000.00
- AVK N/A
- Revenue This Year
- QTRX $13.89
- AVK N/A
- Revenue Next Year
- QTRX $14.79
- AVK N/A
- P/E Ratio
- QTRX N/A
- AVK N/A
- Revenue Growth
- QTRX 14.72
- AVK N/A
- 52 Week Low
- QTRX $7.42
- AVK $9.24
- 52 Week High
- QTRX $29.70
- AVK $12.16
- Technical
- Relative Strength Index (RSI)
- QTRX 30.97
- AVK 42.85
- Support Level
- QTRX $7.49
- AVK $12.21
- Resistance Level
- QTRX $8.29
- AVK $12.34
- Average True Range (ATR)
- QTRX 0.44
- AVK 0.12
- MACD
- QTRX -0.01
- AVK -0.03
- Stochastic Oscillator
- QTRX 8.04
- AVK 15.00
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.
About AVK Advent Convertible and Income Fund
Advent Convertible & Income Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The Fund invests in various sectors, such as communications, utilities, energy, industrial, technology, and others.